Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Anne O. Gang"'
Autor:
Lena Nordström, Tove Wästerlid, Michael Dictor, Mette Merete Pedersen, Catja Freiburghaus, Mats Jerkeman, Anne O. Gang, Peter Nørgaard, Sara Ek, Peter de Nully Brown
Publikováno v:
Leukemia & Lymphoma. 58:1760-1763
Burkitt lymphoma (BL) is a rare, aggressive neoplasm that constitutes 1–2% of adult lymphomas. It derives from mature B-cells in the germinal center and is characterized by a highly proliferative s...
Autor:
Peter Nørgaard, Michael Pedersen, Anne F. Lauritzen, Estrid Høgdall, Anne O. Gang, Peter de Nully Brown, Helle Charlotte Knudsen, Mette Ø. Pedersen, Signe Ledou Nielsen, Tim Svenstrup Poulsen
Publikováno v:
Experimental Hematology. 43:534-536
Topoisomerase (TOP) gene copy number changes may predict response to treatment with TOP-targeting drugs in cancer treatment. This was first described in patients with breast cancer and is currently being investigated in other malignant diseases. TOP-
Autor:
Anne O. Gang, Niels Holmark Andersen, Peter Gimsing, Tobias Wirenfeldt Klausen, Niels Abildgaard, Henrik Gregersen, Annette Juul Vangsted, Ulla Vogel
Publikováno v:
European Journal of Haematology. 85:209-216
Objective: To analyse if patients with early relapse after high-dose chemotherapy with stem cell support (HDT) benefit from new treatment strategies in a population-based setting. Methods: We conducted a retrospective study of relapse treatment and s
Autor:
Michael Pedersen, Michael Boe Møller, Hans Torben Mourits-Andersen, Anne O. Gang, Peter N. Brown, Bo Amdi Jensen, Francesco d'Amore, Paw Jensen, Tobias Wirenfeldt Klausen, Lars Møller Pedersen, Robert Smith Pedersen
Publikováno v:
Gang, A O, Pedersen, M, d'Amore, F, Pedersen, L M, Jensen, B A, Jensen, P, Møller, M B, Mourits-Andersen, H T, Pedersen, R S, Klausen, T W & de N Brown, P 2015, ' A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification : population-based analysis from the Danish Lymphoma Registry ', Leukemia and Lymphoma, vol. 56, no. 9, pp. 2556-2562 . https://doi.org/10.3109/10428194.2015.1010078
Gang, A O, Pedersen, M, d'Amore, F, Pedersen, L M, Jensen, B A, Jensen, P, Moller, M B, Mourits-Andersen, H T, Pedersen, R S, Klausen, T W & De, N B P 2015, ' A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification : Population-based analysis from the Danish Lymphoma Registry ', Leukemia and Lymphoma, vol. 56, no. 9, pp. 2556-2562 . https://doi.org/10.3109/10428194.2015.1010078
Gang, A O, Pedersen, M, d'Amore, F, Pedersen, L M, Jensen, B A, Jensen, P, Moller, M B, Mourits-Andersen, H T, Pedersen, R S, Klausen, T W & De, N B P 2015, ' A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification : Population-based analysis from the Danish Lymphoma Registry ', Leukemia and Lymphoma, vol. 56, no. 9, pp. 2556-2562 . https://doi.org/10.3109/10428194.2015.1010078
The introduction of rituximab and generally improved health among elderly patients have increased the survival of patients with diffuse large B-cell lymphoma (DLBCL). The International Prognostic Index (IPI) from 1992 is based on pre-rituximab data f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53fe296ae55ebfc74e41b3dfbcd76e4
https://pure.au.dk/portal/da/publications/a-clinically-based-prognostic-index-for-diffuse-large-bcell-lymphoma-with-a-cutoff-at-70-years-of-age-significantly-improves-prognostic-stratification(81189750-9f11-47ed-b80d-ff3d5d508d6d).html
https://pure.au.dk/portal/da/publications/a-clinically-based-prognostic-index-for-diffuse-large-bcell-lymphoma-with-a-cutoff-at-70-years-of-age-significantly-improves-prognostic-stratification(81189750-9f11-47ed-b80d-ff3d5d508d6d).html
Autor:
Amy Chadburn, Jenny Zhang, Shawn Levy, Lanie Happ, Anupama Reddy, Tiffany Tzeng, Evelyn T. Nguyen, Jyotishka Datta, Jane Healy, Rex Au-Yeung, Tayla Heavican, Magdalena Czader, Eric Tse, Alexander Waldrop, Peter Nørgaard, Rachel E. Rempel, Sandeep S. Dave, Yok-Lam Kwong, Andrew Clear, David B. Dunson, Elaine S. Jaffe, Javeed Iqbal, Neta Goldschmidt, Kristy L. Richards, Leon Bernal-Mizrachi, Leo Meriranta, Annika Pasanen, Jean L. Koff, Yuri Fedoriw, Mette Merete Pedersen, Deepthi Rajagopalan, Leo I. Gordon, Monika Pilichowska, John G. Gribben, Ora Paltiel, Andrew M. Evens, Gopesh Srivastava, Tushar Dave, Manju Sengar, Angela M. B. Collie, Cassandra Love, Eric D. Hsi, Nicholas S. Davis, Sirpa Leppä, So Young Kim, Maria Calaminici, Qiu Qin, Andrea B. Moffitt, Sarah L. Ondrejka, Ashley D. Staton, Christopher R. Flowers, Shaoying Li, Guojie Li, Waseem Gul Lone, William W.L. Choi, Estrid Høgdall, Marja-Liisa Karjalainen-Lindsberg, Anne O. Gang, Nishitha Reddy
Publikováno v:
Cell. 171:481-494.e15
Diffuse large B cell lymphoma (DLBCL) is the most common form of blood cancer and is characterized by a striking degree of genetic and clinical heterogeneity. This heterogeneity poses a major barrier to understanding the genetic basis of the disease
Autor:
Michael Pedersen, Peter Nørgaard, Anne O. Gang, Tobias Wirenfeldt Klausen, Peter de Nully Brown, Mette Ø. Pedersen, Helle Charlotte Knudsen, Anne F. Lauritzen, Estrid Høgdall, Signe Ledou Nielsen
Publikováno v:
Leukemialymphoma. 56(7)
Addition of etoposide to the R-CHOP chemotherapy regimen with cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab (R-CHOEP) has resulted in improved survival in young patients with high-risk diffuse large B-cell lymphoma (DLBCL). It
Autor:
Anne O. Gang, Martin Hutchings, Karen Dybkær, Tarec Christoffer El-Galaly, Hans Bentzen, Hans Erik Johnsen, Robert Schou Pedersen, Martin Bøgsted, Syed Azhar Ahmad, Anders Ellern Bilgrau, Berit Jamie Nielsen, Karen Juul Mylam, Peter de Nully Brown, Lars Møller Pedersen, Olav J. Bergmann, Maja Bech Juul
Publikováno v:
El-Galaly, T C, Bilgrau, A E, de Nully Brown, P, Juul Mylam, K, Ahmad, S A, Pedersen, L M, Gang, A O, Bentzen, H H, Juul, M B, Bergmann, O J, Pedersen, R S, Nielsen, B J, Johnsen, H E, Dybkaer, K, Bøgsted, M & Hutchings, M 2015, ' A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait ', British Journal of Haematology, vol. 169, no. 3, pp. 435-444 . https://doi.org/10.1111/bjh.13316
El-Galaly, T C, Bilgrau, A E, de Nully Brown, P, Mylam, K J, Ahmad, S A, Pedersen, L M, Gang, A O, Bentzen, H H, Juul, M B, Bergmann, O J, Pedersen, R S, Nielsen, B J, Johnsen, H E, Dybkær, K, Bøgsted, M & Hutchings, M 2015, ' A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait ', British Journal of Haematology, vol. 169, no. 3, pp. 435-444 . https://doi.org/10.1111/bjh.13316
El-Galaly, T C, Bilgrau, A E, de Nully Brown, P, Mylam, K J, Ahmad, S A, Pedersen, L M, Gang, A O, Bentzen, H H, Juul, M B, Bergmann, O J, Pedersen, R S, Nielsen, B J, Johnsen, H E, Dybkær, K, Bøgsted, M & Hutchings, M 2015, ' A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait ', British Journal of Haematology, vol. 169, no. 3, pp. 435-444 . https://doi.org/10.1111/bjh.13316
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this nationwide study we describe the outcome of patients selected for WAW. A coh
Autor:
Henrik Gregersen, Morten Orebo Holmström, Niels Frost Andersen, Niklas Rye Jørgensen, Tobias Wirenfeldt Klausen, Peter Schwarz, Ulla Vogel, Niels Abildgaard, Peter Gimsing, Anne O. Gang, Annette Juul Vangsted
Publikováno v:
Vangsted, A, Klausen, T, Gimsing, P, Abildgaard, N, Andersen, N F, Gang, A O, Holmström, M, Gregersen, H, Vogel, U, Schwarz, P & Jørgensen, N R 2014, ' Genetic variants in the P2RX7gene are associated with risk of multiple myeloma ', European Journal of Haematology, vol. 93, no. 2, pp. 172-174 . https://doi.org/10.1111/ejh.12353
Vangsted, A J, Klausen, T W, Gimsing, P, Abildgaard, N, Andersen, N F, Gang, A O, Holmström, M, Gregersen, H, Vogel, U, Schwarz, P & Jørgensen, N R 2014, ' Genetic variants in the P2RX7 gene are associated with risk of multiple myeloma ', European Journal of Haematology, vol. 93, no. 2, pp. 172-174 . https://doi.org/10.1111/ejh.12353
Vangsted, A J, Klausen, T W, Gimsing, P, Abildgaard, N, Andersen, N F, Gang, A O, Holmström, M, Gregersen, H, Vogel, U, Schwarz, P & Jørgensen, N R 2014, ' Genetic variants in the P2RX7 gene are associated with risk of multiple myeloma ', European Journal of Haematology, vol. 93, no. 2, pp. 172-174 . https://doi.org/10.1111/ejh.12353
The P2 purinoreceptors are proteins that have nucleotides as their natural ligands. The P2RX7 receptor is involved in immune function bone remodelling and stimulation of the receptor induces apoptosis in myeloma cells (1;2). In a population-based stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca694def4d1a54f4a0824e169aa76ce
https://vbn.aau.dk/da/publications/7e32be2b-1ed4-4653-aafc-b1cca1b80f72
https://vbn.aau.dk/da/publications/7e32be2b-1ed4-4653-aafc-b1cca1b80f72
Autor:
Anne F. Lauritzen, Tobias Wirenfeldt Klausen, Signe Lykke Nielsen, Mette Ølgod Pedersen, Anne O. Gang, Peter Nørgaard, Helle Charlotte Knudsen, Tim Svenstrup Poulsen
Publikováno v:
European journal of haematology. 92(1)
In large B-cell lymphoma (LBCL) MYC- and MYC/BCL2 double-hit (DH) translocations have been associated with inferior survival. We hypothesised that the negative prognostic impact of MYC translocation was determined by an immunoglobulin MYC translocati
Autor:
Tim Svenstrup Poulsen, Anne O. Gang, Helle Charlotte Knudsen, Anne F. Lauritzen, Peter Nørgaard, Mette Ø. Pedersen, Uffe O. Gang, Signe Ledou Nielsen
Publikováno v:
European journal of haematology. 89(1)
Concurrent BCL2 and MYC translocations, so called double hit (DH), are a rare finding in large B-cell lymphoma (LBCL). Based on data from retrospective series, DH has been correlated with aggressive clinical behaviour and poor outcome. We conducted a